The effect of Alphabodies® against human lnterleukin lL23 in the transplant model of psoriasis, in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting super-antigen activated peripheral blood cells intradermally into the transplant.
Completed
- Conditions
- een onderzoek naar werking van een middel in een model.Psoriasis1000381610014982
- Registration Number
- NL-OMON39832
- Lead Sponsor
- Complix
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 19
Inclusion Criteria
Patients with light to mild psoriasis vulgaris.
Exclusion Criteria
Volunteers cannot be treated systemically (for psoriasis)
Volunteers cannot have UV/light therapy
Volunteers cannot be taking immune-modulating drugs for other diseases
Volunteers should not have problems with the Köbner phenomenom.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>NVT</p><br>
- Secondary Outcome Measures
Name Time Method <p>NVT</p><br>